Press release
Nucleic Acid Therapeutics Market to Reach USD 13.86 Billion by 2031 Fueled by Genetic Disorder Treatments and R&D Investments
Nucleic Acid Therapeutics Market
According to the latest research by InsightAce Analytic, the Global Nucleic Acid Therapeutics Market is valued at US$ 4.93 billion in 2023, and it is expected to reach US$ 13.86 billion by 2031, with a CAGR of 13.8% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2548
Nucleic acid therapeutics represent a rapidly evolving segment of modern medicine, utilizing therapeutic DNA and RNA molecules to prevent, treat, and manage a broad range of diseases. The market is poised for substantial growth, fueled by increased research and development initiatives aimed at enhancing healthcare systems globally in response to the rising incidence of chronic diseases and genetic disorders. Advancements in biological therapies and DNA-based interventions, coupled with growing demand for innovative pharmaceutical solutions and healthcare services, are further accelerating the expansion of this sector.
Despite the positive outlook, several challenges may temper market growth. These include the high cost of nucleic acid-based therapies, a shortage of skilled professionals with expertise in advanced molecular techniques, and reliance on outdated technological infrastructure in some regions. Nevertheless, the growing emphasis on personalized medicine-where treatments are tailored to an individual's genetic profile-is driving heightened interest in nucleic acid therapeutics. In addition, increased investment by pharmaceutical companies in the development of RNA- and DNA-based therapies, rapid market adoption, and rising global healthcare demand are expected to support the continued advancement and commercialization of these therapies in the years ahead.
List of Prominent Players in the Nucleic Acid Therapeutics Market:
• Novartis
• Moderna Inc
• BioNTech
• Arrowhead Pharmaceuticals
• Merck
• Thermo Fischer Scientific
• Sanofi
• Alnylam Pharmaceuticals
• Sarepta Therapeutics
• Qiagen
• Imugene
• Copernicus Therapeutics Inc.
• Protagonist Therapeutics
• Arbutus Biopharma
• Agilent Technologies
• Silence Therapeutics (UK),
• Astellas Pharma Inc. (Japan),
• CureVac SE (Germany),
• Sirnaomics (US),
• Arcturus Therapeutics Inc. (US)
• Other Market Players
Market Dynamics:
Drivers-
The increasing prevalence of genetic disorders, including cystic fibrosis, muscular dystrophy, and various types of cancer, which often present significant treatment challenges, is driving demand for nucleic acid therapeutics. The expedited advancement of drug discovery and development is being supported by substantial investments in research and development from pharmaceutical companies, government agencies, and academic institutions. Additionally, government initiatives aimed at fostering drug innovation have facilitated a streamlined regulatory approval process and established favorable market conditions, which are expected to further propel industry growth in the coming years.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03
Market Challenges
The growth of the nucleic acid therapeutics market is impeded by several critical challenges. Foremost among these is the high cost of research, development, and manufacturing, which limits patient access due to the significant financial burden associated with these advanced therapies. The complexity of nucleic acid-based treatments also presents considerable technological challenges, particularly in terms of delivery systems, stability, and scalability. Moreover, new entrants face substantial barriers related to stringent regulatory frameworks and lengthy approval processes. Limited awareness and understanding of these therapies among both healthcare providers and the general public further hinder broader adoption, posing an additional constraint on market expansion.
Regional Trends
North America is projected to lead the global nucleic acid therapeutics market in terms of revenue, supported by a strong compound annual growth rate (CAGR) over the forecast period. This growth is largely attributed to the increasing prevalence of chronic conditions such as cancer and diabetes, rising demand for targeted and personalized treatment options, and robust governmental support for cutting-edge medical innovations. Europe also represents a key market, driven by substantial investment in research and development activities that have advanced gene therapy applications and addressed the rising burden of disease. Furthermore, factors such as growing disposable income, population growth, and ongoing improvements in healthcare infrastructure are expected to reinforce market development across the region.
Recent Developments:
• In April 2024, Arrowhead Pharmaceuticals, Inc. announced the dosing of its investigational RNA interference (RNAi) therapeutic, ARO-CFB, in a Phase 1/2a clinical trial. The trial included up to sixty-six healthy volunteers and patients with complement-mediated kidney disease.
• In Aug 2022, Merck and Orna Therapeutics entered into a collaboration agreement to jointly explore, create, and market various initiatives, such as vaccines and treatments, in the fields of infectious disease and oncology.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2548
Segmentation of Nucleic Acid Therapeutics Market-
By Technology-
• RNA Targeted Therapeutics
• Gene Therapies
• Epigenetic and microRNA Modulating Therapies
• Genome Editing Therapies
• Others
By Application-
• Autoimmune Disorders
• Genetic Disorders
• Infectious Diseases
• Cancer
• Others
By End-User-
• Hospitals & Clinics
• Academic & Research Institutes
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/nucleic-acid-therapeutics-market/2548
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nucleic Acid Therapeutics Market to Reach USD 13.86 Billion by 2031 Fueled by Genetic Disorder Treatments and R&D Investments here
News-ID: 4075239 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
GMP Cell Therapy Consumables Market Growth and Restrain Factors Analysis Report …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global GMP Cell Therapy Consumables Market Size, Share & Trends Analysis Report By Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell…
High-End Synthetic Suede Market Study Analysis with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global High-End Synthetic Suede Market Size, Share & Trends Analysis Report By Product (Woven And Non-Woven) And Application (Automotive, Fashion, Furniture And Other Applications (Including Residential And Commercial))- Market Outlook And Industry Analysis 2031"
The High-End Synthetic Suede Market is estimated to reach over USD 2.06 billion by exhibiting a CAGR of 5.75% during the…
Gluten Free Snacks Market
"Green Fertilizer Market" in terms of revenue was estimated to be worth $2.2 billion in 2024 and is poised to reach $ 4.1 Billion by 2034, growing at a CAGR of 6.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1570
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global green fertilizer Market are:
• Technology development
• Shifting tastes of consumers
• Higher…
Gluten Free Snacks Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Gluten Free Snacks Market Size, Share & Trends Analysis Report By Product Type (Nutrition Bars, Candy Bars, Salty Snacks, Nuts), Distributional Channel (Convenience Stores, Supermarket And Hypermarket, Specialty Stores, Drugstores And Pharmacies, E Commerce) And Generation (Millennials, Generation X And Baby Boomers)- Market Outlook And Industry Analysis 2034"
The global gluten free snacks market is estimated…
More Releases for Therapeutics
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
Pruritus Drug Market – Key Players are Cara Therapeutics, Enteris BioPharma, N …
The Pruritus Drug Market research report is a significant investigation of changing business sector elements, driving elements, impediments, and limitations that have been considered the most extensive impacts on market development. Adroit investigative devices, for example, Porter’s Five Forces examination, SWOT examination, and Feasibility examination study have likewise been utilized by the report to offer an exhaustive information of the market. It will go about as a key research report…
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity.
Download the sample report @ https://www.pharmaproff.com/request-sample/1098
It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due…
Global mRNA Cancer Vaccines and Therapeutics Market to 2025| Moderna Therapeutic …
Researchmoz added Most up-to-date research on "Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025" to its huge collection of research reports.
mRNA Cancer Vaccines and Therapeutics Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the mRNA Cancer Vaccines and Therapeutics industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics,…
Global Pruritus Therapeutics Market Report 2019 Companies included Actavis, Trev …
Market Reports Company has recently published 7th edition of Pruritus Therapeutics Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026.
For inquiry or free sample pages email us at: sales@marketreportscompany.com
The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Pruritus Therapeutics market was valued at USD xx…
MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Mode …
WiseGuyReports.Com Publish a New Market Research Report On –“ MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics”.
Description:-
The mRNA Vaccines & Therapeutics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, mRNA Vaccines & Therapeutics market size to maintain the average annual growth rate of XXX from…
